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of the Parasympathetic System 
and Difference in the Outcome 
after ANS Stimulation
Giovanni Minarini
Abstract
The autonomic nervous system has a huge impact on the cardiac regulatory 
mechanism, and many markers exist for evaluating it. In this chapter we are going 
to focus on the RMSSD (Root mean square of successive differences), considered 
the most precise marker for the parasympathetic effector on the heart. Before is 
necessary to learn what the Heart Rate Variability is and how it works, which type 
of range of HRV exists and how we can measure it. Finally, there will be a presenta-
tion of how the RMSSD can be used in different field, and how and why the out-
come can change and what does it mean.
Keywords: autonomic nervous system, sympathetic nervous system, 
parasympathetic nervous system, root mean square of successive differences, heart, 
cardiac mechanism, ANS influence
1. Introduction
Homeostasis can be defined as the result of the stability of physiological systems 
that maintain life; it applies strictly to a limited number of systems such as regula-
tion of pH, concentration of different ions in the extracellular fluid, osmolality 
of extracellular fluid, glucose levels and arterial oxygen tension, which are truly 
essential for life and are therefore maintained within a narrow range for the current 
life history stage [1]. The homeostatic balance is considered as a change of state 
compatible with the actual environmental situations [2]. The temporary variations 
between the “set point” of the homeostatic control system during adaptation to 
internal (i.e. digestion) or external (i.e. climatic condition) perturbations are called 
allostasis [1]. Thus, allostasis is the reaching of physiological stability through a 
change of homeostatic state [1, 3].
The allostatic adaptations during environmental changes are temporary pro-
cesses; if not turned off when not needed, if they occur too frequently or fail to 
occur at all, there may be development of systemic disease(s) such as cardiovascular 
disease, type II diabetes, obesity, etc. [4–6]. Allostatic and homeostatic control 
are ruled by the autonomic nervous system (ANS) integrated within the central 
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nervous system (CNS) [1]. A disorder of the ANS can affect the homeostatic and 
allostatic processes, leading to a risk of developing systemic disorder such as hyper-
tension [7] baroreflex failure for blood pressure regulation [8], type II diabetes or 
affect the immune system and the inflammatory process [9]. Moreover, this has 
been demonstrated how the ANS is strictly correlated to the modulation of pain 
perceived by the subject.
One of the most common markers of the ANS is the rMSSD, square root of the 
mean squared differences of successive NN intervals. It is evaluated through the 
Heart Rate Variability (HRV) and the distance between the peaks of the R values in 
the echocardiogram. The rMSSD allowed the researcher to monitor the alteration in 
the parasympathetic activity with good precision. In this chapter will be explained 
how the rMSDD is related to parasympathetic nervous system, what could modulate 
the outcome and what a different result mean.
2. Heart rate variability
Heart rate variability consists of changes in the time intervals between con-
secutive heartbeats called interbeat intervals (IBIs) [10]. A healthy heart is not a 
metronome. The oscillations of a healthy heart are complex and constantly chang-
ing, which allow the cardiovascular system to rapidly adjust to sudden physical and 
psychological challenges to homeostasis.
The HRV is the fluctuation in time intervals between adjacent heartbeats, 
it indexes neurocardiac function and is generated by heart-brain interactions 
and dynamic non-linear autonomic nervous system (ANS) processes. HRV is an 
emergent property of interdependent regulatory systems which operate on differ-
ent time scales to help us adapt to environmental and psychological challenges by 
stimulating and regulating some vascular component of the allostasis: HRV reflects 
regulation of autonomic balance, blood pressure (BP), gas exchange, gut, heart, 
and vascular tone, which refers to the diameter of the blood vessels that regulate BP, 
and possibly facial muscles [11].
Higher HRV is not always associated to better state of health of the subjects, 
numerous diseases affect the HRV and has the potential to increase this value. 
When cardiac conduction abnormalities cause an increase in the HRV, this is 
strongly linked to increased risk of mortality, particularly among the elderly  
(e.g. causing atrial fibrillation) [12].
Despite that has been demonstrated how optimal level of HRV are associated 
to health and self-regulatory capacity, adaptability and resilience [13, 14]. This is 
due to the vagal modulation of the HRV: heart rate (HR) estimated at any given 
time represents the net effect of the neural output of the parasympathetic (vagus) 
nerves, which slow HR, and the sympathetic nerves, which accelerate it. Opthof 
published a study on the normal range and the determinants of intrinsic heart rate 
in man, following the main research done before on the subject by Jose an Collins in 
1970: he found that a denervated human heart, with no connections to the ANS, the 
intrinsic rate generated by the pacemaker, the Senoatrial Node (SA), is near to 100 
beats per minute [15]. Whenever the rate decrease below this level, it means that 
a parasympathetic outflow is predominating in the balance between sympathetic 
and parasympathetic activity. This happens usually during normal daily activities, 
at rest and when we sleep. On the contrary, if the ratio raises over 100 beats the 
shift is toward the sympathetic system. The average 24 h HR in healthy people is 
approximately 73 bpm. Higher HRs are independent markers of mortality in a wide 
spectrum of conditions [16].
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2.1 Sympathetic and parasympathetic pathways on the heart
Sinus node pacemaker cells activity is continuously under regulation by specific 
neural mechanism.
The SA node is targeted by the descending efferent sympathetic nerves via the 
intrinsic cardiac nervous system and the bulk of the myocardium. Norepinephrine 
and epinephrine release, which increases HR and strengthens the contractility 
of the atria and ventricles, is triggered by these motor neurons action potentials. 
Subsequent the onset of sympathetic stimulus, there is a delay of up to 5 seconds 
before the stimulation induces a progressive rise in HR, which reaches a stable level 
in 20–30 seconds if the stimulus is continuous [17]. A sympathetic stimulus, even if 
brief, can easily affect the HRV rhythm for 5–10 seconds. This is in contrast with the 
vagal stimulation, which is almost instantaneous, due to the acetylcholine degrada-
tion mechanism [17, 18], we will see that later on this chapter. What does that mean? 
That any sudden changes in the HR, up or down, or between the beat, is primarily 
mediated by the parasympathetic nervous system.
The vagus nerves innervate the intrinsic cardiac nervous system. Inside the 
intrinsic cardiac nervous systems are present some synapse between vagus nerve 
and motor neurons that directly project to the sinoatrial node and a portion of the 
surrounding tissue. They trigger acetylcholine release to slow HR. [19] However, 
more than 80% of the efferent preganglionic vagal neurons has connection to local 
circuitry neurons in the intrinsic cardiac nervous system where motor information 
is integrated with inputs from T.
The single efferent vagal stimulation on the SA node is very short, resulting in an 
immediate response that typically occurs within the cardiac circle in which it occurs, 
affecting only 1 or 2 heartbeats after its onset [17]. After cessation of vagal stimulation, 
HR rapidly increases to its previous level. An increase in heart rate can also be achieved 
by reduced vagal activity, or vagal withdrawal. Hence, any sudden increase or decrease 
HR, between 1 beat and the next, are primarily parasympathetically mediated [17, 18].
The medulla oblongata is the major structure integrating incoming afferent 
information from the heart, lungs and face with inputs from cortical and subcorti-
cal structures and is the source of the respiratory modulation of the activity pat-
terns in sympathetic and parasympathetic outflow. The intrinsic cardiac nervous 
system integrates mechanosensitive and chemosensitive neuron inputs with 
efferent information from both the sympathetic and parasympathetic inputs from 
the brain. As a complete system, it affects HRV, vasoconstriction, venoconstriction, 
and cardiac contractility in order to regulate HR and BP [17].
2.2 Heart rate variability frequency band
The European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology Task Force Report on HRV divided heart rhythm oscillations 
into 4 primary frequency bands: high-frequency (HF), low-frequency (LF), very-low-
frequency (VLF), and ultra-low-frequency (ULF) [20]. Most HRV analysis is done in 
5-min segments (of a 24 h recording), although other recording periods are often used. 
When other recording lengths are analyzed, the length of the recording should be 
reported since this has large effects on both HRV frequency and time domain values.
2.2.1 High-frequency band
The HF range is from 0.15 to 0.4 Hz, which correspond to a rhythm period 
between 2.5 and 7 seconds. This band is called the “respiratory band” because 
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correspond to the HR variations related to the respiratory cycle, known also as 
“respiratory sinus arrhythmia”. Is conventionally recorded over a minimum 1 min 
period. For infants and children, who breathe faster than adults, the resting range 
can be adjusted to 0.24–1.04 Hz [21]. A complex regulatory mechanism involving 
both central and reflex interaction is the main organizer of this system. During 
inhalation there is an acceleration in the heart rate due to an inhibition of the vagal/
outflow from the cardio-respiratory center. On the opposite, while exhaling, the 
vagal outflow is restored to a normal level resulting in slowing the HR.
The HF modulation has also psychological involvement: reduced vagally medi-
ated HRV has been related to a reduced self-regulatory capacity and cognitive func-
tions that involve the executive centers of the prefrontal cortex. This is consistent 
with the finding that lower HF power is associated with stress, panic, anxiety, or 
worry. It has to be noted how this reaction is due a reduction of the parasympathetic 
activity, and not to an increase in sympathetic ones. This has been shown by numer-
ous studies, where a total vagal blockade obtained pharmacologically eliminates the 
HF oscillations and reduces power in the LF range, resulting in a strong reduction of 
the HRV, including LF and VLF bands. Thus, they concluded that HRV is a resultant 
of the parasympathetic mechanism.
High-frequency power is highly correlated with the pNN50 and RMSSD time-
domain measures [22]. HF band power may increase at night and decrease during 
the day [10].
2.2.2 Low-frequency band
LF range is between 0.04 and 0.15 Hz, which equates to rhythms or modula-
tions periods between 7 and 25 seconds. Is typically recorded over a minimum 
2 min period [23]. This range of action was called the “baroreceptor range” or 
“mid-frequency band”, due to its strong correlation with baroreceptor activity 
at rest [10, 24]. Baroreceptors are stretch-sensitive mechanoreceptors located in 
vena cavae, carotid sinuses, aortic arch and heart chambers. The ones found in the 
carotid are the most sensitive. Baroreflex is transported to the brain by the vagus 
nerve and represent the beat-to-beat change in HR per unit of change in systolic 
blood pressure [25]. A decreased baroreflex is related to aging and weakened 
regulatory capacity [26].
There is a different influence of the sympathetic and parasympathetic system 
inside this band, due to the rhythms: above 0.1 Hz the SNS seems to be lesser 
influent, whilst the parasympathetic affect heart rhythms down to 0.05 Hz [27, 28]. 
There rhythms are obtained during slow respiration rates, where a vagal activity 
easily generates oscillations in the heart rhythms crossing into the LF band [29, 30]. 
Therefore, when the respiratory rates are below 8.5 per minutes, or 1 in 7 seconds, 
or when a subject take a deep breath there is a vagal mediation influence.
Despite has been generally accepted the LF band has a marker for the sympa-
thetic activity, and the LF/HF ratio is used to assess the balance between SNS and 
PNS, is still not totally clear if in resting condition the Low Frequency band reflect 
the baroreflex activity instead of the cardiac sympathetic innervation [31–33].
2.2.3 Very-low-frequency band
The VLF is the power in the range between 0.0033 and 0.04 Hz, which equates 
to rhythms or modulations with periods that occur between 25 and 300 seconds. 
Although all 24 h clinical measures of HRV reflecting low HRV are linked with 
increased risk of adverse outcomes, the VLF band has stronger associations with all-
cause mortality than the LF and HF bands [34–37]. Low VLF power has been shown 
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to be associated with arrhythmic death [38] and posttraumatic stress disorder 
(PTSD) [39]. Moreover, low power expression in this band has been associated with 
high inflammation [40, 41] and has been correlated with low levels of testosterone. 
In contrast, other biochemical markers, such as those mediated by the hypotha-
lamic–pituitary–adrenal (HPA) Axis axis (e.g., cortisol), did not [42]. Longer time 
periods using 24 h HRV recordings should be obtained to provide comprehensive 
assessment of VLF and ULF fluctuations [22].
Historically, is still not well defined the physiological explanation and mecha-
nisms involved in the generation of the VLF component, compared to the LF and 
HF components. Despite the accuracy and the most predictive outcomes, this area 
has been largely ignored even. Long-term regulatory mechanisms and ANS activity 
related to thermoregulation, the renin-angiotensin system, and other hormonal 
factors appear to contribute to this band [43, 44].
Very-low-frequency power is strongly correlated with the SDNNI time-domain 
measure, which averages 5 min standard deviations for all NN intervals over a 24 h 
period. There is uncertainty regarding the physiological mechanisms responsible 
for activity within this band [14]. The heart’s intrinsic nervous system appears to 
contribute to the VLF rhythm and the SNS influences the amplitude and frequency 
of its oscillations [20].
Based on work by Armor [45] and Kember et al. [32, 46], the VLF rhythm 
appears to be generated by the stimulation of afferent sensory neurons in the heart. 
This, in turn, activates various levels of the feedback and feed-forward loops in the 
heart’s intrinsic cardiac nervous system, as well as between the heart, the extrinsic 
cardiac ganglia, and spinal column. This experimental evidence suggests that the 
heart intrinsically generates the VLF rhythm and efferent SNS activity due to physi-
cal activity and stress responses modulates its amplitude and frequency.
2.2.4 Ultra-low-frequency band
The ultra-low-frequency band (ULF) falls below 0.0033 Hz (333 seconds or 
5.6 minutes). Oscillations or events in the heart rhythm with a period of 5 minutes 
or greater are reflected in this band and it can only be assessed with 24 h and longer 
recordings [22]. The circadian oscillation in HR is the primary source of the ULF 
power, although other very slow-acting regulatory processes, such as core body 
temperature regulation, metabolism, and the renin-angiotensin system likely add 
to the power in this band [20]. The Task Force Report on HRV suggests that 24 h 
recordings should be divided into 5-min segments and that HRV analysis should be 
performed on the individual segments prior to the calculation of mean values. This 
effectively filters out any oscillations with periods longer than 5 minutes. However, 
when spectral analysis is applied to entire 24 h records, several lower frequency 
rhythms are easily detected in healthy individuals [23].
There is disagreement about the contribution by the PNS and SNS to this band. 
Different psychiatric disorders show distinct circadian patterns in 24 h HRs, par-
ticularly during sleep [25, 47].
2.3 Heart rate variability measurement
Three types of measurement exist for the HRV, time-domain index, frequency-
domain index and non-linear measurements. Time-domain indices quantify the 
amount of HRV observed during monitoring periods that may range from ~2 min 
to 24 h. Frequency-domain values calculate the absolute or relative amount of signal 
energy within component bands. Non-linear measurements allow us to quantify the 
unpredictability of a time series.
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2.3.1 Time domain measurements of heart rate variability
Time domain measures are the simplest to calculate. Time domain measures do not 
provide a means to adequately quantify autonomic dynamics or determine the rhyth-
mic or oscillatory activity generated by the different physiological control systems. 
However, since they are always calculated the same way, data collected by different 
researchers are comparable but only if the recordings are exactly the same length of 
time and the data are collected under the same conditions. Time domain indices quan-
tify the amount of variance in the inter-beat-intervals (IBI) using statistical measures. 
The three most important and commonly reported time domain measures are the 
standard deviation of normal-to-normal (SDNN), the SDNN index, and the root mean 
square of successive differences (RMSSD) are the most commonly reported metrics.
2.3.2 The standard deviation of the normal-to-normal
The SDNN is the standard deviation of the normal-to-normal (NN) sinus-
initiated IBIs measured in milliseconds. This measure reflects the ebb and flow 
of all the factors that contribute to HRV. In 24 h recordings, the SDNN is highly 
correlated with ULF and total power [48]. In short-term resting recordings, the 
primary source of the variation is parasympathetically mediated, especially with 
slow, deep breathing protocols. However, in ambulatory and longer term recordings 
the SDNN values are highly correlated with lower frequency rhythms [23]. Thus, 
low age-adjusted values predict morbidity and mortality. For example, patients with 
moderate SDNN values (50–100 milliseconds) have a 400% lower risk of mortality 
than those with low values (0–50 milliseconds) in 24 h recordings [49, 50].
2.3.3 Standard deviation of the normal-to-normal index
The SDNN index is the mean of the standard deviations of all the NN intervals 
for each 5 min segment. Therefore, this measurement only estimates variability 
due to the factors affecting HRV within a 5 min period. In 24 h HRV recordings, 
it is calculated by first dividing the 24 h record into 288 five-minute segments and 
then calculating the standard deviation of all NN intervals contained within each 
segment. The SDNN index is the average of these 288 values [20]. The SDNN index 
is believed to primarily measure autonomic influence on HRV. This measure tends 
to correlate with VLF power over a 24 h period [23].
2.3.4 The root mean square of successive differences
The RMSSD is the root mean square of successive differences between normal 
heartbeats. This value is obtained by first calculating each successive time difference 
between heartbeats in milliseconds. Each of the values is then squared and the result 
is averaged before the square root of the total is obtained. The RMSSD reflects the 
beat-to-beat variance in HR and is the primary time domain measure used to estimate 
the vagally mediated changes reflected in HRV [20]. The RMSSD is correlated with 
HF power and therefore also reflects self-regulatory capacity as discussed earlier [23].
3. Root mean square of successive differences as PNS marker
As aforementioned, the RMSSD reflects the vagally mediated changes in the 
relation that occur between two peaks in the R value of an echocardiogram, thus 
give to the researcher an overview of the PNS activity.
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The parasympathetic modification evaluation is one of the most used param-
eters and find its utility in different research [51, 52]. Accordingly, to Zygmunt 
and Stanczyk [53], the rMSSD “describes short-term variations, and thus reflects 
parasympathetic activities”. Although the HRV and rMSSD does not reflect perfectly 
the tonic activity of parasympathetic and sympathetic, but rather the resultant on 
the effector, that are sinus cells node receptors; the vagal activity is predominant 
compared to sympathetic one. Influence of parasympathetic is fast and transient, 
due to acetylcholine degradation by acetylesterase. These physiological redundan-
cies cause parasympathetic activities to be visible in the cycle that follows the 
stimulus, whilst the sympathetic stimulation develop more slowly, and their effects 
are visible only after 2–3 s, causing slower oscillation with higher amplitude [54]. 
One concern regarding this issue is that HRV studies are quite sensitive to a number 
of factors as eloquently pointed out by Piché and Descarreaux [55], which can make 
data interpretation challenging.
Due to the ambiguity in physiological meaning in low frequency (LF) variations 
during short recording periods [20] the Time Domain Indices (rMSSD) has revealed 
itself more reliable than frequency domain [56], and considered as PNS modula-
tion indices [20]. R-R intervals is a time domain measure of HRV calculated by 
the equation of Kim et al. [57]. According to Hayward et al. [58], the rMSSD time 
domain measurement has high sensitivity to identify ANS modification in temporal 
window of 1–2 minutes, concordant to Thong et al. [59] who found how rMSSD is a 
valuable measurement for ultra-short-term records (1–5 minutes) due to its ability 
to be improved by combining disjoint records; e.g. combining 6 rMSSD records of 
10 seconds each to obtain the equivalent of a 60 seconds length rMMSD registra-
tion. Moreover, Esco and Flat [60] showed and almost perfect relationship between 
ultra-short-term and criterion measures (5 minutes) by recording rMSSD in 23 
athletes pre- and post-exercises.
3.1 RMSSD modulation with physical activity
RMSSD is often used for professional athletes in order to monitor cardiac activ-
ity and modulation of the HRV subsequentially to physical performance. Acute 
decreases in HRV have been reported to occur following intense endurance training 
[61], resistance training [62], and competition [63]. Therefore, low HRV is com-
monly thought to provide a reflection of acute fatigue from training or competing.
But despite what has been accepted for the last years, recent discovery shows 
how not always an increase in this value is a positive result.
In the context of monitoring fatigue or training status in athletes, a common 
belief is that high HRV is good and low HRV is bad. Or, in terms of observing the 
overall trend, increasing HRV trends are good, indicative of positive adaptation or 
increases in fitness. Decreasing trends are bad, indicative of fatigue accumulation or 
“overtraining” and performance decrements.
Unfortunately, an increasing HRV trend throughout training is not always 
a good thing and thus should not always be interpreted as such. In fact, several 
studies have reported increasing HRV trends in overtrained athletes predominately 
involved in endurance sports. For example, Le Meur et al. [64] showed decreased 
maximal incremental exercise performance and increased weekly HRV mean values 
in elite endurance athletes following a 3 week overload period, compared to a con-
trol group who saw no changes. Following a taper, performance supercompensation 
was observed along with a return of HRV toward baseline.
He most common response to overload training is a progressive decrease in 
HRV. This is your typical alarm response to a stressor, where the sympathetic arm of 
the autonomic nervous system is activated. In this situation, resting HR is elevated 
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and HRV decreases. With insufficient recovery time, HRV may not fully recover to 
baseline before the next training stimulus and thus will result in a downward trend 
when this cycle is perpetuated. An intense day of training can result in suppressed 
HRV for up to 72 hours post-exercise [65]. With the higher training frequencies and 
training volumes often associated with overload periods, it makes sense that HRV 
will show a decreasing trend. Typically, HRV will respond first with a decreasing 
trend and performance decrements will follow if the overload period is sustained.
A study by Pichot et al. [66] provides a good example of a decreasing HRV trend 
in response to overload training. They showed that middle distance runners saw a 
progressive downward HRV trend (up to −43%) during a 3 week overload period. 
In week 4, training loads were reduced and HRV recovered and exceeded baseline 
values.
These aspects demonstrate a new aspect of the RMSSD modulation due to a 
physical stimulus, and the complexity of the cardiac regulation mechanism.
3.2 RMSSD application inside the psychological field
Altered cardiac autonomic functions in form of reduced Heart Rate Variability 
(HRV) have been found to be associated with increased cardiovascular morbidity 
and mortality in depressive patients.
Most studies have now identified depression as a strong and independent 
risk factor for cardiovascular disease even in physically healthy individuals [67] 
and also for adverse cardiovascular outcomes such as mortality [68]. Although 
the underlying pathophysiological mechanism is yet to be elucidated, autonomic 
imbalance has been projected as one of the underlying mechanisms [69]. Heart Rate 
Variability (HRV) is a useful non-invasive measure for assessing cardiac autonomic 
modulations.
Reduced HRV has been reported in several studies done in depressed patients 
both with and without cardiovascular diseases compared to non-depressed subjects 
[70, 71]. Although negative studies have been reported as well, which were unable 
to prove an association [72]. Most of the researches carried out to observe the 
association between HRV and depression have been done in individuals who were 
already either having Cardiovascular Disease (CVD) besides depression or were on 
medications [73].
A meta-analysis done by Kemp et al., in depression patients without cardiovas-
cular diseases also reported the association between reduced HRV and depression 
and was found to be more in severely depressed individuals [74].
In addition, Agelink et al., showed the inverse correlation of parasympathetic 
HRV values with the severity of depression [75]. In a recent study Wang et al., 
also observed higher LF, LF:HF Ratio and lower SDNN, RMSSD and HF values in 
depression group compared to control group [52].
4. Conclusion
The rMSSD can be a very useful tool for many relevant findings: from the para-
sympathetic activation to a marker for cardiac dysfunction. Despite the findings 
and the large are of application, it is still an unknown area.
The correlation between the psychological issues and the rMSSD value add a 
deeper meaning on how the body is strictly correlated to the mind, and the interre-
lation between the thought and its physical response. Many research has been done 
regarding the heart and its physiology and mechanism, but only now we are starting 
to really understand how this tissue really works, and for better comprehend how 
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this organ is connected to the body and how it respond to the numerous different 
stimuli throughout the day, is necessary to delineate a clear structure of evaluation 
capable of considering also these new aspect, like the psychological impact and the 
psychological response.
Author details
Giovanni Minarini
Studio Alphaomega, Modena, Italy
*Address all correspondence to: giovanni.minarini@gmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Autonomic Nervous System Monitoring - Heart Rate Variability
[1] McEwen BS, Wingfield JC. The 
concepts of allostasis in biology and 
biomedicine. Hormones and Behavior. 
2003;43:2-15
[2] Janig W. Homeostasis and Allostasys. 
In: The Integrative Action of the 
Autonomic Nervous System. Vol. 2. 
Cambridge: Cambridge University 
Press; 2008. 1p
[3] Schulkin J. Allostasis: A neural 
behavioral perspective. Hormones and 
Behavior. 2003;43:21-27
[4] Bjorntop P. Behavior and metabolic 
disease. International Journal of 
Behavioral Medicine. 1997;2:285-302
[5] Folkow B, Schmidt T, Uvnas- 
Moberg K. Stress, health and the 
social environment. Acta Physiologica 
Scandinavica. 1997;161(640):1-179
[6] McEwen BS. Neurobiology of 
interpreting and responding to 
stressful events: Paradigmatic role 
of the hippocampus. In: Handbook 
of Physiology. Section 7: The 
Endocrine System, Vol. IV, Coping 
with the Environment: Neural and 
Neuroendocrine Mechanisms. Oxford 
New York: Oxford University Press; 
2001. pp. 155-178
[7] Grassi G, Serravalle G. Sympatho-
vagal imbalance in hypertension. In: 
Robertson D, Biaggioni I, Burnstock G, 
Low PA, Paton JFR, editors. Primer 
on the Autonomic Nervous System. 
Amsterdam: Elsevier; 2012
[8] Jordan J. Baroreflex failure. In: 
Robertson D, Biaggioni I, Burnstock G, 
Low PA, Paton JFR, editors. Primer 
on the Autonomic Nervous System. 
Croydon, UK: Academic Press; 2012. 
pp. 349-353
[9] Marvar PJ, Harrison DG. 
Inflammation, immunity and the 
autonomic nervous system. In: 
Robertson D, Biaggioni I, Burnstock G, 
Low PA, Paton JFR, editors. Primer 
on the Autonomic Nervous System. 
Amsterdam: Elsevier; 2012
[10] McCraty R, Shaffer F. Heart rate 
variability: New perspectives on 
physiological mechanisms, assessment 
of self-regulatory capacity, and health 
risk. Global Advances in Health and 
Medicine. 2015;4(1):46-61
[11] Gevirtz RN, Lehrer PM, 
Schwartz MS. Cardiorespiratory 
biofeedback. In: Schwartz MS, 
Andrasik F, editors. Biofeedback: A 
Practitioner’s Guide. 4th ed. New York: 
The Guilford Press; 2016. pp. 196-213
[12] Stein PK, Domitrovich PP, Hui N, 
Rautaharju P, Gottdiener J. Sometimes 
higher heart rate variability is 
not better heart rate variability: 
Results of graphical and nonlinear 
analyses. Journal of Cardiovascular 
Electrophysiology. 2005;16(9):954-959
[13] McCraty R, Atkinson M, 
Tomasino D, Bradley RT. The Coherent 
Heart: Heart-Brain Interactions, 
Psychophysiological Coherence, 
and the Emergence of System-Wide 
Order. Boulder Creek, CA: Institute of 
Heartmath; 2009
[14] Segerstrom SC, Nes LS. Heart 
rate variability reflects self-
regulatory strength, effort, and 
fatigue. Psychological Science. 
2007;18(3):275-281
[15] Opthof T. The normal range and 
determinants of the intrinsic heart 
rate in man. Cardiovascular Research. 
2000;45(1):173-176
[16] Palatini P. Elevated heart rate as a 
predictor of increased cardiovascular 
morbidity. Journal of Hypertension. 
Supplement. 1999;17(3):S3-S10
References
11
Root Mean Square of the Successive Differences as Marker of the Parasympathetic System…
DOI: http://dx.doi.org/10.5772/intechopen.89827
[17] Hainsworth R. The control and 
physiological importance on heart rate. 
In: Malik M, Camm AJ, editors. Heart 
Rate Variability. Armonk, NY: Futura 
Publishing Company, Inc; 1995
[18] Lacey BC, Lacey JI. Two-way 
communication between the heart 
and the brain. Significance of time 
within the cardiac cycle. The American 
Psychologist. 1978;33(2):99-113
[19] Armour JA. Anatomy and function 
of the intrathoracic neurons regulating 
the mammalian heart. In: Zucker IH, 
Gilmore JP, editors. Reflex Control of 
the Circulation. Boca Raton, FL: CRC 
Press; 1991. pp. 1-37
[20] Task Force of the European Society 
of Cardiology, North American Society 
of Pacing and Electrophysiology. 
Heart rate variability standards 
of measurement, physiological 
interpretation, and clinical use. 
Circulation. 1996;93(5):1043-1065
[21] Quintana DS, Elstad M, 
Kaufmann T, Brandt CL, Haatveit B, 
Haram M, et al. Resting-state high-
frequency heart rate variability is 
related to respiratory frequency in 
individuals with severe mental illness 
but not healthy controls. Scientific 
Reports. 2016;6:37212. DOI: 10.1038/
srep37212
[22] Kleiger RE, Stein PK, Bigger JT. 
Heart rate variability: Measurement and 
clinical utility. Annals of Noninvasive 
Electrocardiology. 2005;10:88-101. DOI: 
10.1111/j.1542-474X.2005.10101.x
[23] Shaffer F, McCraty R, Zerr CL. A 
healthy heart is not a metronome: 
An integrative review of the heart’s 
anatomy and heart rate variability. 
Frontiers in Psychology. 2014;5:1040. 
DOI: 10.3389/fpsyg.2014.01040ù
[24] Malliani A. Association of heart 
rate variability components with 
physiological regulatory mechanisms. 
In: Malik M, Camm AJ, editors. Heart 
Rate Variability. Armonk NY: Futura 
Publishing Company, Inc; 1995. 
pp. 173-188
[25] Bowers EJ, Murray A. Effects on 
baroreflex sensitivity measurements 
when different protocols are used to 
induce regular changes in beat-to-
beat intervals and systolic pressure. 
Physiological Measurement. 
2004;25(2):523-538
[26] Bristow JD, Gribbin B, Honour AJ, 
Pickering TG, Sleight P. Diminished 
baroreflex sensitivity in high blood 
pressure and ageing man. The Journal of 
Physiology. 1969;202(1):45-46
[27] de Boer RW, Karemaker JM, 
Strackee J. Hemodynamic fluctuations 
and baroreflex sensitivity in humans: 
A beat-to-beat model. The American 
Journal of Physiology. 1987;253(3 Pt 
2):H680-H689
[28] Baselli G, Cerutti S, Badilini F, 
Biancardi L, Porta A, Pagani M, et al. 
Model for the assessment of 
heart period and arterial pressure 
variability interactions and of 
respiration influences. Medical & 
Biological Engineering & Computing. 
1994;32(2):143-152
[29] Ahmed AK, Harness JB, Mearns AJ. 
Respiratory control of heart rate. 
European Journal of Applied 
Physiology. 1982;50:95-104
[30] Tiller WA, McCraty R, Atkinson M. 
Cardiac coherence: A new, noninvasive 
measure of autonomic nervous system 
order. Alternative Therapies in Health 
and Medicine. 1996;2(1):52-65
[31] Eckberg DL. Human sinus 
arrhythmia as an index of vagal 
cardiac outflow. Journal of 
Applied Physiology: Respiratory, 
Environmental and Exercise Physiology. 
1983;54(4):961-966
Autonomic Nervous System Monitoring - Heart Rate Variability
12
[32] Kember GC, Fenton GA, Armour JA, 
Kalyaniwalla N. Competition model 
for aperiodic stochastic resonance in 
a Fitzhugh-Nagumo model of cardiac 
sensory neurons. Physical Review. E, 
Statistical, Nonlinear, and Soft Matter 
Physics. 2001;63(4 Pt 1):041911
[33] MacKinnon S, Gevirtz R, McCraty R, 
Brown M. Utilizing heartbeat evoked 
potentials to identify cardiac regulation 
of vagal afferents during emotion 
and resonant breathing. Applied 
Psychophysiology and Biofeedback. 
2013;38(4):241-255
[34] Tsuji H, Venditti FJ, Manders ES, 
Evans JC, Larson MG, Feldman CL, 
et al. Reduced heart rate variability and 
mortality risk in an elderly cohort. The 
Framingham heart study. Circulation. 
1994;90(2):878-883
[35] Schmidt H, Müller-Werdan U, 
Hoffmann T, Francis DP, 
Piepoli MF, Rauchhaus M, et al. 
Autonomic dysfunction predicts 
mortality in patients with multiple 
organ dysfunction syndrome of 
different age groups. Critical Care 
Medicine. 2005;33(9):1994-2002
[36] Hadase M, Azuma A, Zen K, et al. 
Very low frequency power of heart 
rate variability is a powerful predictor 
of clinical prognosis in patients with 
congestive heart failure. Circulation 
Journal. 2004;68(4):343-347
[37] Tsuji H, Larson MG, Venditti FJ Jr, 
Manders ES, Evans JC, Feldman CL, 
et al. Impact of reduced heart rate 
variability on risk for cardiac events. 
The Framingham heart study. 
Circulation. 1996;94(11):2850-2855
[38] Bigger JT Jr, Fleiss JL, Steinman RC,  
Rolnitzky LM, Kleiger RE, Rottman JN. 
Frequency domain measures of heart 
period variability and mortality after 
myocardial infarction. Circulation. 
1992;85(1):164-171
[39] Shah AJ, Lampert R, Goldberg J, 
Veledar E, Bremner JD, Vaccarino V. 
Posttraumatic stress disorder and 
impaired autonomic modulation in 
male twins. Biological Psychiatry. 
2013;73(11):1103-1110
[40] Lampert R, Bremner JD, Su S, 
et al. Decreased heart rate variability 
is associated with higher levels 
of inflammation in middle-aged 
men. American Heart Journal. 
2008;156(4):759.e1-759.e7
[41] Carney RM, Freedland KE, 
Stein PK, et al. Heart rate variability 
and markers of inflammation and 
coagulation in depressed patients 
with coronary heart disease. 
Journal of Psychosomatic Research. 
2007;62(4):463-467
[42] Theorell T, Liljeholm-Johansson Y, 
Björk H, Ericson M. Saliva testosterone 
and heart rate variability in the 
professional symphony orchestra after 
“public faintings” of an orchestra 
member. Psychoneuroendocrinology. 
2007;32(6):660-668
[43] Akselrod S, Gordon D, Ubel FA,  
Shannon DC, Berger AC, Cohen RJ. 
Power spectrum analysis of heart rate 
fluctuation: A quantitative probe of 
beat-to-beat cardiovascular control. 
Science. 1981;213(4504):220-222
[44] Cerutti S, Bianchi AM, 
Mainardi LT. Spectral analysis of 
the heart rate variability signal. In: 
Malik M, Camm AJ, editors. Heart 
Rate Variability. Armonk NY: Futura 
Publishing Company, Inc; 1995. 
pp. 63-74
[45] Armour JA. Neurocardiology: 
Anatomical and Functional Principles. 
Boulder Creek, CA: Institute of 
HeartMath; 2003
[46] Kember GC, Fenton GA, 
Collier K, Armour JA. Aperiodic 
stochastic resonance in a hysteretic 
13
Root Mean Square of the Successive Differences as Marker of the Parasympathetic System…
DOI: http://dx.doi.org/10.5772/intechopen.89827
population of cardiac neurons. Physical 
Review E. 2000;61:1816-1824. DOI: 
10.1103/PhysRevE.61.1816
[47] Armour JA. Peripheral autonomic 
neuronal interactions in cardiac 
regulation: Neurocardiology. In: 
Armour JA, Ardell JL, editors. 
New York: Oxford University Press; 
1994. pp. 219-244
[48] Umetani K, Singer DH, McCraty R, 
Atkinson M. Twenty-four hour time 
domain heart rate variability and 
heart rate: Relations to age and gender 
over nine decades. Journal of the 
American College of Cardiology. 
1998;31(3):593-601
[49] Stein PK, Domitrovich PP, 
Huikuri HV, Kleiger RE. Cast 
investigators. Traditional and 
nonlinear heart rate variability are each 
independently associated with mortality 
after myocardial infarction. Journal 
of Cardiovascular Electrophysiology. 
2005;16(1):13-20
[50] Kleiger RE, Miller JP, Bigger JT Jr, 
Moss AJ. Decreased heart rate variability 
and its association with increased 
mortality after acute myocardial 
infarction. The American Journal of 
Cardiology. 1987;59(4):256-262
[51] Koenig J, Jarczok MN, Ellis RJ, 
Warth M, Hillecke TK. Lowered 
parasympathetic activity in apparently 
healthy subjects with self-reported 
symptoms of pain: Preliminary results 
from a pilot study. Pain Practice. 
2015;15:314-318
[52] Wang Y, Zhao X, O’Neil A, 
Turner A, LiuEmail X. Altered cardiac 
autonomic nervous function in 
depression. BMC Psychiatry. 
2013;13:187
[53] Zygmunt A, Stanczyk J. Methods of 
evaluation of autonomic nervous system 
function. Archives of Medical Science. 
2010;6(1):11-18
[54] Pinna GD, Maestri R, Torunski A. 
Heart rate variability measures: A fresh 
look at reliability. Clinical Science. 
2007;113:131-140
[55] Piché M, Descarreaux M. Heart 
rate variability modulation after 
manipulation in pain-free patients 
vs patients in pain? The importance 
of controlling for respiration rate 
changes. Journal of Manipulative 
and Physiological Therapeutics. 
2010;33:554-555
[56] Al Haddad H, Laursen PB,  
Chollet D, Ahmaidi S, Buchheit M. 
Reliability of resting and postexercise 
heart rate measures. International 
Journal of Sports Medicine. 
2011;32:598-605
[57] Kim KK, Lim YG, Kim JS, Park KS. 
Effect of missing RR-interval data on 
heart rate variability analysis in the time 
domain. Physiological Measurement. 
2007;28(12):1458-1494
[58] Hayward C, Patel H, Manohar S, 
Waton J, Middleton L, Wardle A, et al. 
Heart rate variability, assessed in one 
minute windows, provides insight into 
the time course of changes in autonomic 
nervous system activity. Journal of 
the American College of Cardiology. 
2015;65(10)
[59] Thong T, Li K, McNames J, Aboy M, 
Goldstein B. Accuracy of ultra-short 
heart rate variability measures. In: 
Proceedings of the 25th Annual 
International Conference of the IEEE 
Engineering in Medicine and Biology 
Society. Vol. 3. 2003. pp. 2424-2427
[60] Esco MR, Flatt AA. Ultra-short-
term heart rate variability indexes 
at rest and post-exercise in athletes: 
Evaluating the agreement with accepted 
recommendations. Journal of Sports 
Science and Medicine. 2014;13:535-541
[61] Plews DJ, Laursen PB, Kilding AE, 
Buchheit M. Heart rate variability and 
Autonomic Nervous System Monitoring - Heart Rate Variability
14
training intensity distribution in elite 
rowers. International Journal of Sports 
Physiology and Performance. 2014
[62] Chen JL, Yeh DP, Lee JP, 
Chen CY, Huang CY, Lee SD, et al. 
Parasympathetic nervous activity 
mirrors recovery status in weightlifting 
performance after training. The Journal 
of Strength & Conditioning Research. 
2011;25(6):1546-1552
[63] Edmonds RC, Sinclair WH, 
Leicht AS. Effect of a training week 
on heart rate variability in elite youth 
rugby league players. International 
Journal of Sports Medicine. Dec 
2013;34(12):1087-1092
[64] Le Meur Y, Pichon A, Schaal K,  
Schmitt L, Louis J, Gueneron J,  
et al. Evidence of parasympathetic 
hyperactivity in functionally 
overreached athletes. Medicine 
and Science in Sports and Exercise. 
2013;45(11):2061-2071
[65] Stanley J, Peake JM, Buchheit M. 
Cardiac parasympathetic reactivation 
following exercise: Implications for 
training prescription. Sports Medicine. 
2013;43(12):1259-1277
[66] Pichot V, Roche F, Gaspoz JM, 
Enjolras F, Antoniadis A, Minini P, et al. 
Relation between heart rate variability 
and training load in middle-distance 
runners. Medicine and Science in Sports 
and Exercise. 2000;32(10):1729-1736
[67] Gan Y, Gong Y, Tong X, Sun H, 
Cong Y, Dong X, et al. Depression and 
the risk of coronary heart disease: A 
meta-analysis of prospective cohort 
studies. BMC Psychiatry. 2014;14:371
[68] Freedland KE, Carney RM. 
Depression as a risk factor for adverse 
outcomes in coronary heart disease. 
BMC Medicine. 2013;11:131
[69] Huffman JC, Celano CM, Beach SR, 
Motiwala SR, Januzzi JL. Depression 
and cardiac disease: Epidemiology, 
mechanisms and diagnosis. 
Cardiovascular Psychiatry and 
Neurology. 2013;2013:1-14
[70] Glassman AH, Bigger JT, 
Gaffney M, Vanzyl LT. Heart rate 
variability in acute coronary syndrome 
patients with major depression: 
Influence of sertraline and mood 
improvement. Archives of General 
Psychiatry. 2007;64:1025-1031
[71] Kemp AH, Quintana DS, 
Felmingham KL, Matthews S, 
Jelinek HF. Depression, comorbid 
anxiety disorders and heart rate 
variability in physically healthy, 
unmedicatedpatients: Implications 
for cardiovascular risk. PLoS One. 
2012;7:e30777
[72] Gehi A, Mangano D, Pipkin S, 
Browner WS, Whooley MA. Depression 
and heart rate variability in patients 
with stable coronary heart disease: 
Findings from the heart and soul 
study. Archives of General Psychiatry. 
2005;62:661-666
[73] Carney RM, Freedland KE. 
Depression and heart rate variability in 
patients with coronary heart disease. 
Cleveland Clinic Journal of Medicine. 
2009;76:13-17
[74] Kemp AH, Quintana DS, Gray MA, 
Felmingham KL, Brown K, Gatt JM. 
Impact of depression and antidepressant 
treatment on heart rate variability: A 
review and meta-analysis. Biological 
Psychiatry. 2010;67:1067-1074
[75] Agelink MW, Majewski T, 
Wurthmann C, Postert T, Linka T, 
Rotterdam S, et al. Autonomic 
neurocardiac function in patients 
with major depression and effects 
of antidepressive treatment with 
nefazodone. Journal of Affective 
Disorders. 2001;62:187-198
